Publication

Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia

Davidson, Bruce L.
Tapson, Victor F.
Irwin, Richard S.
French, Cynthia L.
Elliott, C. Gregory
Levi, Marcel
Embargo Expiration Date
Abstract

Antiseptic mouthwash use to control coronavirus disease 2019 (COVID-19) has been proposed, disputed, and dismissed without understanding the proposal and without serious consideration of merits and counterarguments. Adding a proven, safe, and evidence-based clinically reasonable measure to existing approaches of universal masking and social distancing, while awaiting a safe and effective vaccine, seems a constructive approach worth implementing and observing for efficacy. We describe how adding pharyngeal antisepsis, “washing the throat,” before sleeping, when healthy adults of all ages aspirate material from above the larynx, can help protect individuals against COVID-19 pneumonia and, hence, help protect society. We also address critiques presented against widespread adoption of pharyngeal antisepsis.

Source

Davidson BL, Tapson VF, Irwin RS, French CL, Elliott CG, Levi M. Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia. Am J Med. 2020 Dec 15:S0002-9343(20)31114-1. doi: 10.1016/j.amjmed.2020.12.001. Epub ahead of print. PMID: 33338507. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1016/j.amjmed.2020.12.001
PubMed ID
33338507
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License